Clozapine vs. Haloperidol: Antipsychotic effects on sexual function in schizophrenia

Sexuality and Disability

Volumn 18, Issue 1, 2000, Pages 41-48

  Covington, Louis ^a   Cola, Phillip A ^b  

^a University Hospitals of Cleveland ^*  (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Antipsychotics; Disability; Schizophrenia; Sexual function

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DRUG EFFICACY; FEMALE; HUMAN; INTIMACY; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SEXUALITY;

EID: 0034085510     PISSN: 01461044     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005425728062     Document Type: Article

References (17)

1. Jablensky, A: The 100-year epidemiology of schizophrenia. Schizophrenia Research 28:111-125, 1997.
2. Satriano J, Cournos F, Guido J, et al.: Psychiatric facilities and AIDS: An institutional response. International Conference on AIDS 9(2):843 (abstract no. PO-D 13-3751) June 6-11, 1993.
3. Rupp A, Keith SJ: The costs of schizophrenia assessing the burden. Psychiatric Clinics of North America 16(2):413-423, 1993.
4. Seidman SN, Reider RO: A review of sexual behavior in the United States. American Journal of Psychiatry 151:330-341, 1994.
5. Kane J, Honigfeld G, Singer J, et al.: Clozaril for the treatment-resistant schizophrenic: A double blind comparison with chlorpromazine. Archives of General Psychiatry 45:789-796, 1988.
6. Buchanan RW, Breier A, Kirkpatrick B, Ball P, Carpenter WT: Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. American Journal of Psychiatry 155:6, 751-760, 1998.
7. Meltzer HY: Dimensions of outcomes with clozapine. British Journal of Psychiatry 160:17(Suppl):46-53, 1992.
8. Meltzer HY: New drugs for the treatment of schizophrenia. Psychiatric Clinics of North America: Schizophrenia 16:365-385, 1993.
9. Buchanan RW, Holstein C, Breier A: The comparative efficacy and long term effect of Clozapine treatment on neuropsychological test performance. Biological Psychiatry 36:717-725, 1994.
10. Collaborative Working Group on Clinical Trial Evaluations. Adverse effects of the atypical antipsychotics. Journal of Clinical Psychiatry 59 (suppl 12):17-22, 1989.
11. Hansen TE, Casey DE, Hoffman WF: Neuroleptic intolerance. Schizophrenia Bulletin 23(14):567-582, 1997.
12. Gitlin MJ: Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. Journal of Clinical Psychiatry, 55:406-413, 1994.
13. Carr V: The role of the general practitioner in the treatment of schizophrenia: specific issues. Medical Journal of Australia 166:143-146, 1997.
14. Endicott J, Spitzer, RL: A diagnostic review: The schedule for affective disorders and schizophrenia. Archives of General Psychiatry 35:837-844, 1978.
15. Gittleman-Klein R, Klein DF: Premorbid asocial adjustment and prognosis in schizophrenia. Journal of Psychiatric Research 7:35-53, 1969.
16. Andreasen NC: Scale for the assessment of negative symptoms. @ Nancy C Andreasen, University of Iowa, 1984.
17. Heinrichs DW, Hanlon TE, Carpenter WT: The quality of life scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin 10:388-398, 1984.